We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.125 | -7.14% | 1.625 | 1.60 | 1.65 | 1.75 | 1.525 | 1.75 | 63,456,389 | 16:19:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.71 | 8.8M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2021 15:33 | Not a nice feeling for those that bought, seeing NT to sell | oilisgold | |
09/2/2021 15:32 | That's their own fault if they panicked and soldAnyone who has done any research will know to hold until figures for BC become clearer | hooded claw | |
09/2/2021 15:28 | not a nice feeling if some have sold out and now being quoted N T to buy in again especially as getting closer to mid February The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing. David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations | bunz3 | |
09/2/2021 15:25 | with NT to buy some who have sold might not be so pleased if they finding it difficult to buy back in again ,if mms are running low with share supply | bunz3 | |
09/2/2021 15:22 | Richard, answer my question fool. Rns was it from a buyer? | oilisgold | |
09/2/2021 15:21 | Non stop selling. Sellers still selling | oilisgold | |
09/2/2021 15:21 | He is a loser working for nobody. Sold too early now is green with envy | richardp19 | |
09/2/2021 15:21 | Richard, was the RNS stating a buyet? | oilisgold | |
09/2/2021 15:20 | Soo many sellers selling. RNS was off a seller not a buyer | oilisgold | |
09/2/2021 15:20 | Very easy to sell you clown as you wouldn't know because you dnt own anyo shares | richardp19 | |
09/2/2021 15:20 | Sellers not letting tjis rise. NT TO SELL AGAIN | oilisgold | |
09/2/2021 15:19 | Mote buyets now | oilisgold | |
09/2/2021 15:18 | if rns is released ,and if mms look to be running low with share supply be interesting to see how much they move share price up | bunz3 | |
09/2/2021 15:18 | I do and I've been scaling in every day for the last week! | actybod | |
09/2/2021 15:18 | Oil working for his master so he can buy in lower.Best to filter it. | hooded claw | |
09/2/2021 15:16 | you can sell ,not so easy to buy , they looking to be running low with share supply is a rns close | bunz3 | |
09/2/2021 15:16 | Actybod, you clearly have no idea what is coming.All you see is the rise.What you should see is the market cap. | hooded claw | |
09/2/2021 15:10 | After such a rise? | actybod | |
09/2/2021 15:08 | its would be a dream come true if DB gets out an RNS at this moment !! | pal44 | |
09/2/2021 15:06 | Well hope shorters get caught out by a big juicy rns from budd! | yasyas1 | |
09/2/2021 15:05 | Was hoping for this to stabilise around £1.5. Dissapointing drop | yasyas1 | |
09/2/2021 15:03 | looking strong for a good finish,will another rns be released before end of trading then two TR1 yesterday afternoon | bunz3 | |
09/2/2021 15:00 | Sellers 4 to 1 | oilisgold | |
09/2/2021 14:59 | We dropped from 140p to 129p. Worrying times. At this rate we be in red | oilisgold |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions